Abbott Net Debt To E B I T D A from 2010 to 2024
| ABT Stock | USD 105.92 0.37 0.35% |
Net Debt To EBITDA | First Reported 2010-12-31 | Previous Quarter 0.84808692 | Current Value 0.81 | Quarterly Volatility 0.89700489 |
Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 B, Interest Expense of 605.1 M or Selling General Administrative of 6.2 B, as well as many exotic indicators such as Price To Sales Ratio of 5.01, Dividend Yield of 0.0176 or PTB Ratio of 2.62. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
Abbott | Net Debt To E B I T D A |
Latest Abbott Laboratories' Net Debt To E B I T D A Growth Pattern
Below is the plot of the Net Debt To E B I T D A of Abbott Laboratories over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company’s net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Abbott Laboratories' Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Net Debt To E B I T D A | 10 Years Trend |
|
Net Debt To E B I T D A |
| Timeline |
Abbott Net Debt To E B I T D A Regression Statistics
| Arithmetic Mean | 1.38 | |
| Geometric Mean | 1.12 | |
| Coefficient Of Variation | 64.95 | |
| Mean Deviation | 0.65 | |
| Median | 1.15 | |
| Standard Deviation | 0.90 | |
| Sample Variance | 0.80 | |
| Range | 3.586 | |
| R-Value | 0.07 | |
| Mean Square Error | 0.86 | |
| R-Squared | 0 | |
| Significance | 0.81 | |
| Slope | 0.01 | |
| Total Sum of Squares | 11.26 |
Abbott Net Debt To E B I T D A History
About Abbott Laboratories Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Abbott Laboratories income statement, its balance sheet, and the statement of cash flows. Abbott Laboratories investors use historical funamental indicators, such as Abbott Laboratories's Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may use each financial statement separately, they are all related. The changes in Abbott Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abbott Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Abbott Laboratories Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Abbott Laboratories. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt To EBITDA | 0.85 | 0.81 |
Pair Trading with Abbott Laboratories
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.Moving together with Abbott Stock
| 0.65 | CNC | Centene Corp | PairCorr |
Moving against Abbott Stock
| 0.82 | DXR | Daxor | PairCorr |
| 0.6 | GCTK | GlucoTrack | PairCorr |
| 0.56 | ELYM | Eliem Therapeutics Trending | PairCorr |
| 0.44 | ELV | Elevance Health Financial Report 17th of July 2024 | PairCorr |
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Abbott Laboratories Correlation against competitors. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 2.12 | Earnings Share 3.21 | Revenue Per Share 23.183 | Quarterly Revenue Growth 0.022 |
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.